Peginterferon lambda for the treatment of patients admitted to hospital with COVID-19: a phase 2, placebo-controlled randomised trial
Kandel et al., Clinical Microbiology and Infection, doi:10.1016/j.cmi.2025.08.003
https://c19early.org/kandel.html